Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ceribell (CBLL) EBITDA (2023 - 2025)

Ceribell (CBLL) has disclosed EBITDA for 3 consecutive years, with -$13.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA fell 7.4% year-over-year to -$13.5 million, compared with a TTM value of -$53.3 million through Dec 2025, down 31.64%, and an annual FY2025 reading of -$53.3 million, down 31.64% over the prior year.
  • EBITDA was -$13.5 million for Q4 2025 at Ceribell, down from -$13.3 million in the prior quarter.
  • Across five years, EBITDA topped out at -$8.4 million in Q4 2023 and bottomed at -$13.6 million in Q2 2025.
  • Average EBITDA over 3 years is -$11.3 million, with a median of -$12.6 million recorded in 2024.
  • Peak annual rise in EBITDA hit 7.4% in 2025, while the deepest fall reached 52.47% in 2025.
  • Year by year, EBITDA stood at -$8.4 million in 2023, then crashed by 50.05% to -$12.6 million in 2024, then dropped by 7.4% to -$13.5 million in 2025.
  • Business Quant data shows EBITDA for CBLL at -$13.5 million in Q4 2025, -$13.3 million in Q3 2025, and -$13.6 million in Q2 2025.